244 results on '"Jenny Lin"'
Search Results
102. Applying EEG in consumer neuroscience
- Author
-
Samantha N.N. Cross, Meng-Hsien (Jenny) Lin, Terry L. Childers, and William J. Jones
- Subjects
Marketing ,medicine.diagnostic_test ,Computer science ,Management science ,media_common.quotation_subject ,05 social sciences ,Cognition ,Electroencephalography ,Field (computer science) ,Terminology ,03 medical and health sciences ,0302 clinical medicine ,Originality ,0502 economics and business ,medicine ,050211 marketing ,Consumer neuroscience ,Marketing research ,030217 neurology & neurosurgery ,Consumer behaviour ,media_common - Abstract
Purpose This paper aims to review past papers focused on understanding consumer-related topics in marketing and related interdisciplinary fields to demonstrate the applications of electroencephalogram (EEG) in consumer neuroscience. Design/methodology/approach In addition to the review of papers using EEG to study consumer cognitive processes, the authors also discuss relevant decisions and considerations in conducting event-related potential (ERP) studies. Further, a framework proposed by Plassmann et al. (2015) was used to discuss the applications of EEG in marketing research from papers reviewed. Findings This paper successfully used Plassmann et al.’s (2015) framework to discuss five applications of neuroscience to marketing research. A review of growing EEG studies in the field of marketing and other interdisciplinary fields reveals the advantages and potential of using EEG in combination with other methods. This calls for more research using such methods. Research limitations/implications A technical overview of ERP-related terminology provides researchers with a background for understanding and reviewing ERP studies. A discussion of method-related considerations and decisions provides marketing researchers with an introduction to the method and refers readers to relevant literature. Practical implications The marketing industry has been quick to adopt cutting edge technology, including EEG, to understand and predict consumer behavior for the purpose of improving marketing practices. This paper connects the academic and practitioner spheres by presenting past and potential EEG research that can be translatable to the marketing industry. Originality/value The authors review past literature on the use of EEG to study consumer-related topics in marketing and interdisciplinary fields, to demonstrate its advantages over-traditional methods in studying consumer-relevant behaviors. To foster increasing use of EEG in consumer neuroscience research, the authors further provide technical and marketing-specific considerations for both academic and market researchers. This paper is one of the first to review past EEG papers and provide methodological background insights for marketing researchers.
- Published
- 2018
103. Understanding olfaction and emotions and the moderating role of individual differences
- Author
-
Samantha N.N. Cross, Terry L. Childers, and Meng-Hsien (Jenny) Lin
- Subjects
Marketing ,Mechanism (biology) ,05 social sciences ,Consumer research ,Automatic processing ,Olfaction ,Stimulus exposure ,050105 experimental psychology ,Event-related potential ,0502 economics and business ,050211 marketing ,0501 psychology and cognitive sciences ,Psychology ,Cognitive psychology - Abstract
Purpose The purpose of this paper is to explore the mediating role of emotions in processing scent information in consumer research, using event-related potential (ERP)-based neuroscience methods, while considering individual differences in sense of smell. Design/methodology/approach Prior research on olfaction and emotions in marketing has revealed mixed findings on the relationship between olfaction and emotion. The authors review earlier studies and present a neuroscience experiment demonstrating the benefits of ERP methods in studying the automatic processing of emotions. Findings Results demonstrate how emotional processes occurring within 1s of stimulus exposure differ across individuals with varying olfactory abilities. Findings reveal an automatic suppression mechanism for individuals sensitive to smell. Research limitations/implications Scent-induced emotions demonstrated through the use of ERP-based methods provide insights for understanding automatic emotional processes and reactions to ambient scents by consumers in the marketplace. Practical implications Findings show an automatic suppression of emotions triggered by scent in individuals sensitive to smell. Marketers and retailers should consider such reactions when evaluating the use of olfactory stimuli in promotional and retail strategies. Originality/value The authors review past literature and provide an explanation for the disparate findings in the olfaction–emotion linkage, by studying individual differences in response to scent in the marketplace. This is one of the first papers in marketing to introduce the application of ERP in studying consumer-relevant behavior and provide technical and marketing-specific considerations for both academic and market researchers.
- Published
- 2018
104. Managing Children's Internet Advertising Experiences: Parental Preferences for Regulation
- Author
-
Meng-Hsien Jenny Lin, Russell N. Laczniak, and Akshaya Vijayalakshmi
- Subjects
Government ,Internet use ,Sociology and Political Science ,business.industry ,media_common.quotation_subject ,education ,05 social sciences ,050801 communication & media studies ,Advertising ,Online advertising ,Preference ,Faith ,0508 media and communications ,Locus of control ,0502 economics and business ,050211 marketing ,The Internet ,Parental perception ,business ,Psychology ,General Economics, Econometrics and Finance ,media_common - Abstract
Recent research suggests that children are spending a significant amount of time on the Internet which increases their exposure to subtle, engaging, and interactive ads. As a result, policy makers have developed regulations intended to empower parents to manage their children's exposure to Internet advertising. However, prior research has not examined parental perceptions of these regulations. This article aims to identify (1) parents' regulatory preferences regarding children's exposure to Internet advertising and (2) whether (and how) parents' locus of control (LOC) drives their regulation preferences. Findings reveal that internal‐LOC parents prefer parental responsibility while external‐LOC parents prefer government regulations, parental responsibility, and involvement of independent organizations and firms. External‐LOC parents' preference is mediated by their concerns about Internet advertising and their tendency to have faith in regulation. Policy makers can use the findings to develop guidelines that better assist parents in influencing their children's Internet use.
- Published
- 2018
105. Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
- Author
-
Lucia Kwak, So Yeon Kim, Guru Sonpavde, Elad Sharon, Abdul Rafeh Naqash, Alessio Cortellini, Rana R McKay, Toni K Choueiri, Thomas Marron, Amin H Nassar, Jeffrey A Sparks, Kaushal Parikh, Frank Aboubakar Nana, Jenny Linnoila, Shruti Gupta, Nicole R LeBoeuf, Elio Adib, Ahmad Al-Hader, Edward El-Am, Dory Freeman, Ahmed Bilal Khalid, Marita Salame, Elias Bou Farhat, Arjun Ravishankar, Bachar Ahmad, David Kaldas, Andrea Malgeri, Ole-Petter R Hamnvik, Thomas Dilling, Elie Najem, Talal El Zarif, Serena Rahme, Caiwei Zhong, and Tarek H Mouhieddine
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Patients with paraneoplastic syndromes (PNS) are excluded from clinical trials involving immune checkpoint inhibitors (ICIs) due to safety concerns. Moreover, real-world data on efficacy and safety is scarce.Methods In this retrospective study, data were collected on patients with PNS and solid tumors receiving ICI between 2015 and 2022 at nine institutions. Patients were classified into: Cohort 1 (pre-existing PNS before ICI initiation), cohort 2 (PNS during ICI treatment), and cohort 3 (PNS after ICI discontinuation). Patients with metastatic non-small cell lung cancer (NSCLC) (mNSCLC) from cohort 1 were matched to patients who were PNS-free at each institution up to a 1:3 ratio for age, sex, type of ICI, use of concurrent chemotherapy, and number of lines of systemic therapy prior to ICI initiation. Kaplan-Meier method was used to assess overall survival (OS) and time-to-next treatment (TTNT).Results Among 109 patients with PNS treated with ICIs, median age at ICI initiation was 67 years (IQR: 58–74). The most represented cancer type was NSCLC (n=39, 36%). In cohort 1 (n=55), PNS exacerbations occurred in 16 (29%) patients with median time to exacerbation after ICI of 1.1 months (IQR: 0.7–3.3). Exacerbation or de novo PNS prompted temporary/permanent interruption of ICIs in 14 (13%) patients. For cohort 2 (n=16), median time between ICI initiation and de novo PNS was 1.2 months (IQR: 0.4–3.5). Treatment-related adverse events (trAEs) occurred in 43 (39%) patients. Grade ≥3 trAEs occurred in 18 (17%) patients. PNS-directed immunosuppressive therapy was required in 55 (50%) patients. We matched 18 patients with mNSCLC and PNS (cohort 1) to 40 without PNS, treated with ICIs. There was no significant difference in OS or TTNT between patients with mNSCLC with and without PNS, although a trend was seen towards worse outcomes in patients with PNS. TrAEs occurred in 6/18 (33%) and 14/40 (35%), respectively. Grade ≥3 trAEs occurred in 4 (22%) patients with PNS and 7 (18%) patients without PNS.Conclusions Exacerbations of pre-existing PNS occurred in 29% of patients treated with ICIs and both exacerbations and de novo PNS occur early in the ICI course. TrAE from ICIs were similar between patients with and without PNS. Our data suggest that pre-existing PNS should not preclude consideration of ICI therapy although patients may not derive the same clinical benefit compared with patients without PNS.
- Published
- 2024
- Full Text
- View/download PDF
106. Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems
- Author
-
Ching-Yu Wang, Li-Ting Ho, Lian-Yu Lin, Hsing-Min Chan, Hung-Yi Chen, Tung-Lin Yu, Yu-Sen Huang, Sung-Hsin Kuo, Wen-Jeng Lee, and Jenny Ling-Yu Chen
- Subjects
CyberKnife ,Linear accelerator ,Cardiac radioablation ,Ventricular tachycardia ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Few dosimetric comparisons have been published between linear accelerator (LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac radio-ablation in ventricular tachycardia. This study aimed to compare the dosimetry of noninvasive cardiac radio-ablation deliverable on LA with that on CK. Methods Thirteen patients who underwent noninvasive cardiac radio-ablation by LA were included. The prescribed dose was 25 Gy in 1 fraction, and the average planning target volume was 49.8 ± 31.0 cm3 (range, 14.4–93.7 cm3). CK plans were generated for comparison. Results Both the CK and LA plans accomplished appropriate dose coverage and normal tissue sparing. Compared with the LA plans, the CK plans achieved significantly lower gradient indices (3.12 ± 0.71 vs. 3.48 ± 0.55, p = 0.031) and gradient measures (1.00 ± 0.29 cm vs. 1.17 ± 0.29 cm, p 50 cm3 or a non-spherical PTV, the LA and CK plans were similar regarding dosimetric parameters. CK plans involved more beams (232.2 ± 110.8 beams vs. 10.0 ± 1.7 arcs) and longer treatment times (119.2 ± 43.3 min vs. 22.4 ± 1.6 min, p = 0.007). Conclusions Both CK and LA are ideal modalities for noninvasive cardiac radio-ablation. Upfront treatment should be considered based on clinical intent.
- Published
- 2023
- Full Text
- View/download PDF
107. Web-based tool to assess breast cancer risk for women presenting to a gynecologic oncology visit
- Author
-
Eloise Chapman-Davis, Daniel Litvin, Hannah Krinsky, Karen Bolouvi, Melissa K. Frey, Jenny Lin, Kevin Holcomb, Nora Badiner, and Evelyn Cantillo
- Subjects
medicine.medical_specialty ,Framingham Risk Score ,medicine.diagnostic_test ,business.industry ,Obstetrics and Gynecology ,Cancer ,Gynecologic oncology ,medicine.disease ,Breast cancer ,Oncology ,Family medicine ,medicine ,Breast screening ,business ,Risk assessment ,Genetic testing ,Family health history - Abstract
Objectives: Approximately 40,000 women die from breast cancer each year in the United States, highlighting the importance of identifying high-risk women prior to breast cancer development. Risk models exist, including the Tyrer-Cusick (TC) model but have not been widely implemented due to the time required to perform the risk assessment and interpret results. We aim to report our experience with a web-based application (WBA) to complete the TC model for women prior to a scheduled gynecologic oncology clinic visit. Methods: All patients scheduled for a gynecologic oncology new patient appointment between 9/2020-9/2021 were offered enrollment in an institutional review board-approved prospective trial. Patients were randomized to standard of care gynecologic oncology visit versus utilization of a WBA completed either at home or in the office prior to the appointment (randomized 1:1:1). The WBA collects personal and family health history and utilizes this information to generate a TC score. As part of the trial protocol, all women with a TC score reflecting a lifetime risk of breast cancer ≥ 20% were referred to the institution's high risk breast clinic which provides counseling on genetic testing, breast screening and breast cancer prevention. The WBA also generated additional information on personal and family cancer, the results of which are reported separately. Results: Sixty-six patients were randomized to utilization of the WBA which included completion of the TC model. Median patient age was 60 (range 22-88). Twenty-six patients (39.4%) did not complete the model for the following reasons: 13 (50%) were not able to access the application, 11 (42.3%) did not answer all required questions and 4 (15.4%) were ineligible due to prior breast cancer. Forty patients (60.6%) successfully completed the TC model and among those patients, 6 (15%) had a significantly elevated lifetime breast cancer risk score (defined as ≥ 20%), all of whom were referred to a high risk breast clinic. Conclusions: The COVID-19 pandemic has pressed the healthcare system to better utilize technology to provide safe and equitable medical care. A WBA for collection of personal and family health history and generation of cancer risk models completed prior to the physician appointment is an exciting application of such technology. When piloted in a gynecologic oncology practice, 60.6% of patients were able to complete the risk model and 15% of these patients were found to have a significantly elevated breast cancer risk warranting follow-up care.
- Published
- 2021
108. Web-based tools for family cancer history and cancer risk modeling: what are the barriers to successful implementation?
- Author
-
Nora Badiner, Muhammad Danyal Ahsan, Eloise Chapman-Davis, Hannah Krinsky, Karen Bolouvi, Kevin Holcomb, Corbyn Nchako, Evelyn Cantillo, Melissa K. Frey, Jenny Lin, and Daniel Litvin
- Subjects
medicine.medical_specialty ,Oncology ,Family Cancer History ,business.industry ,Family medicine ,Obstetrics and Gynecology ,Web application ,Medicine ,business ,Cancer risk - Published
- 2021
109. Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy
- Author
-
Jenny Lin, Courtney McCracken, Curtis Travers, Durga Shah, and Sumit Verma
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,Physiology ,business.industry ,Duchenne muscular dystrophy ,Disease progression ,Electromyography ,medicine.disease ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Physical medicine and rehabilitation ,Interquartile range ,030225 pediatrics ,Physiology (medical) ,Internal medicine ,Quantitative electromyography ,Ambulatory ,Biomarker (medicine) ,Medicine ,Neurology (clinical) ,medicine.symptom ,business ,Myopathy ,030217 neurology & neurosurgery - Abstract
Introduction This study's objective was to evaluate quantitative electromyography (QEMG) using multiple-motor-unit (multi-MUP) analysis in Duchenne muscular dystrophy (DMD). Methods Ambulatory DMD boys, aged 5–15 years, were evaluated with QEMG at 6-month intervals over 14 months. EMG was performed in the right biceps brachii (BB) and tibialis anterior (TA) muscles. Normative QEMG data were obtained from age-matched healthy boys. Wilcoxon signed-rank tests were performed. Results Eighteen DMD subjects were enrolled, with a median age of 7 (interquartile range 7–10) years. Six-month evaluations were performed on 14 subjects. QEMG showed significantly abnormal mean MUP duration in BB and TA muscles, with no significant change over 6 months. Conclusions QEMG is a sensitive electrophysiological marker of myopathy in DMD. Preliminary data do not reflect a significant change in MUP parameters over a 6-month interval; long-term follow-up QEMG studies are needed to understand its role as a biomarker for disease progression. Muscle Nerve, 2017
- Published
- 2017
110. The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud
- Author
-
Andrea Wakefield, Barry van der Strate, Elizabeth Groeber, Saadya Fatmi, Jing Tu, John Allinson, Yansheng Liu, Hanna Ritzén, John Kamerud, Maria Cruz Caturla, Phyllis Conliffe, Zhongping John Lin, Rafiq Islam, Kayode Awaiye, Chad Briscoe, Jenny Lin, Javier Torres, James Hulse, Jim Yamashita, Shane Karnik, Anahita Keyhani, Simona Rizea Savu, Yinghe Li, Nicola Hughes, Rabab Tayyem, Patrick Bennett, Mike Buonarati, Laura Cojocaru, Wei Garofolo, Steve Lowes, Prashant Kale, Afshin Safavi, Dominic Warrino, Mohammed Bouhajib, Paul Rhyne, Michele Malone, Stephanie Mowery, Bruce Stouffer, Mathilde Yu, Daniel Tang, Masood Khan, Ira DuBey, Neil Adcock, Nadine Boudreau, Radha Shekar, Ardeshir Khadang, Edward O'Connor, Christina Satterwhite, Edward Tabler, Philippe Couerbe, Ron Shoup, Adriana Iordachescu, Jennifer Zimmer, Eric Thomas, Natasha Savoie, Jenifer Vija, Rhonda Johnson, Stephanie Cape, Clark V. Williard, Christina Sanchez, Kai Kurylak, Chris Beaver, Corey Nehls, James Bourdage, Mohamed Osman, Brent Matthews, Roger Hayes, Luigi Silvestro, and Michele Fiscella
- Subjects
Research Report ,Bioanalysis ,Computer science ,Clinical Biochemistry ,Stability (learning theory) ,Guidelines as Topic ,Sample (statistics) ,Bioinformatics ,030226 pharmacology & pharmacy ,01 natural sciences ,Chemistry Techniques, Analytical ,Analytical Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Drug Stability ,Acceptance testing ,Data integrity ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,Notice ,Data Collection ,Matrix stability ,010401 analytical chemistry ,General Medicine ,Sample stability ,0104 chemical sciences ,Medical Laboratory Technology ,Engineering management ,Pharmaceutical Preparations ,Government Regulation ,Biomarkers - Abstract
The 10th Global CRO Council (GCC) Closed Forum was held in Orlando, FL, USA on 18 April 2016. In attendance were decision makers from international CRO member companies offering bioanalytical services. The objective of this meeting was for GCC members to meet and discuss scientific and regulatory issues specific to bioanalysis. The issues discussed at this closed forum included reporting data from failed method validation runs, GCP for clinical sample bioanalysis, extracted sample stability, biomarker assay validation, processed batch acceptance criteria, electronic laboratory notebooks and data integrity, Health Canada's Notice regarding replicates in matrix stability evaluations, critical reagents and regulatory approaches to counteract fraud. In order to obtain the pharma perspectives on some of these topics, the first joint CRO–Pharma Scientific Interchange Meeting was held on 12 November 2016, in Denver, Colorado, USA. The five topics discussed at this Interchange meeting were reporting data from failed method validation runs, GCP for clinical sample bioanalysis, extracted sample stability, processed batch acceptance criteria and electronic laboratory notebooks and data integrity. The conclusions from the discussions of these topics at both meetings are included in this report.
- Published
- 2017
111. Unavailability of Outpatient Medications: Examples and Opportunities for Management
- Author
-
Rosie Nguyen, Milena M. McLaughlin, Pratixa Patel, Jenny Lin, and Erin R. Fox
- Subjects
Drug ,business.industry ,media_common.quotation_subject ,Pharmaceutical Science ,Economic shortage ,medicine.disease ,030226 pharmacology & pharmacy ,03 medical and health sciences ,0302 clinical medicine ,Community pharmacy ,Community pharmacist ,Health care ,Commentary ,Medicine ,030212 general & internal medicine ,Drug reaction ,Medical emergency ,Unavailability ,business ,media_common - Abstract
Drug shortages create significant challenges for patients and health care providers. Pharmacists play important roles in managing medication therapy during drug shortages. The management of drug shortages by the community pharmacist is an expanding role. Adverse drug reactions and delayed treatments are highlighted in the literature as some of the consequences of outpatient drug shortages; it is likely these harms are underreported. This commentary reviews examples and opportunities for the management of outpatient drug shortages.
- Published
- 2017
112. Method Development and Validation for the Determination of Pravastatin in Human Plasma by Lc-Ms/Ms
- Author
-
Lian Chen, Andrii Piatkivskyi, Paresh Joshi, Kalem Aguilar, and Jenny Lin
- Subjects
Analyte ,Acetic acid ,chemistry.chemical_compound ,Bioanalysis ,Chromatography ,Calibration curve ,Chemistry ,Liquid–liquid extraction ,Extraction (chemistry) ,Analytical chemistry ,Pharmaceutical Science ,Isobaric process ,Tandem mass spectrometry - Abstract
A simple, rapid, sensitive and selective liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated for the quantification of pravastatin in human plasma. Pravastatin-D3 was used as an internal standard. The analyte was extracted from human plasma samples by liquid-liquid extraction technique. Due to the presence of isobaric metabolites, 3α-iso-pravastatin and 6-epi-pravastatin, chromatographic conditions were optimized, with a C18 column by using a mixture of 0.1% acetic acid in water and acetonitrile/methanol (43:57, v/v) as the mobile phase at a flow rate of 0.6 mL/min. The calibration curve obtained was linear (r2 ≥ 0.9900) over the concentration range of 0.500-500 ng/mL. Method validation was performed as per FDA guidelines and the results met the acceptance criteria. The method was suitable for supporting clinical studies.
- Published
- 2017
113. GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline
- Author
-
Xinping Fang, Cheikh Kane, Valentine Barra, Dawn Dufield, Marsha Luna, Adriane Spytko, Jerome Bergeron, Corey Nehls, Robert MacNeill, Andrew Dinan, Esme Farley, Scott Reuschel, Hao Wang, Chantal DiMarco, Timothy Sangster, John Stamatopoulos, Shane Karnik, Nadine Boudreau, Kathie Lindley, Sarah Maasjo, Ariana Tudoroniu, Changming Yang, Jennifer Vance, Christina Satterwhite, Hao Feng, Ira DuBey, Jing Shi, Natasha Savoie, Brian K. Hoffpauir, Kurt J. Sales, Travis Harrison, Orlando Bravo, Jenifer Vija, Jason Ambrosius, Ardeshir Khadang, Chad Briscoe, Stephanie Cape, Edward Tabler, Philippe Couerbe, Adriana Iordachescu, Evgueni Fedorov, Jennifer Zimmer, Roger Hayes, Luca Matassa, Michael H. Buonarati, Franklin Spriggs, Stacie McCown, Michael E. Brown, Wei Garofolo, Jenny Lin, John Lindsay, Paul Rhyne, Shelby Anderson, Bruce Stouffer, Rafiq Islam, John Pirro, Edward Wells, Angie Underberg, Saadya Fatmi, Philip Joyce, Shaolian Zhou, Mohammed Bouhajib, Joseph Bower, Hanna Ritzén, and Liam Moran
- Subjects
Engineering ,Medical education ,Validation study ,Bioanalysis ,business.industry ,Event (computing) ,Clinical Biochemistry ,Attendance ,Reproducibility of Results ,Guidelines as Topic ,General Medicine ,Guideline ,Analytical Chemistry ,Medical Laboratory Technology ,Research Design ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,business ,Biomarkers - Abstract
The 13th GCC Closed Forum for Bioanalysis was held in New Orleans, Louisiana, USA on April 5th, 2019. This GCC meeting was organized to discuss the contents of the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline published in February 2019 and consolidate the feedback of the GCC members. In attendance were 63 senior-level participants from eight countries representing 44 bioanalytical CRO companies/sites. This event represented a unique opportunity for CRO bioanalytical experts to share their opinions and concerns regarding the ICH M10 Bioanalytical Method Validation Draft Guideline and to build unified comments to be provided to the ICH.
- Published
- 2019
114. 12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicity
- Author
-
Ira DuBey, Marc Moussallie, Nadia Kulagina, Dave Williams, Corey Nehls, Rabab Tayyem, Michael E. Brown, Wei Garofolo, Edward Tabler, Philippe Couerbe, Ardeshir Khadang, John Lindsay, Michele Malone, Paul Rhyne, Anahita Keyhani, Mark Warren, Jennifer Zimmer, John Stamatopoulos, Sian Estdale, Clark V. Williard, Bruce Stouffer, Eric Thomas, Mathilde Yu, Rafiq Islam, George Hristopoulos, Simona Rizea Savu, Robert MacNeill, Edward Wells, Jenny Lin, Hanna Ritzén, Iohann Boulay, Natasha Savoie, Kayode Awaiye, Vellalore Kakkanaiah, Shane Karnik, Christina Satterwhite, Curtis Sheldon, Amanda Hays, Chad Briscoe, Kathie Lindley, Colin Barry, Yi Qun Xiao, Andrew Dinan, Allan Xu, Luca Matassa, Arron Xu, Lawrence Goodwin, Steve Lowes, Jessica St Charles, Chantal Di Marco, Mohammed Bouhajib, Maria Cruz Caturla, Nicola Hughes, Patrick Bennett, Jenifer Vija, Stephanie Cape, Roger Hayes, Hao Wang, Xinping Fang, James Bourdage, Franklin Spriggs, and Chris Beaver
- Subjects
Societies, Scientific ,Bioanalysis ,Certification ,Immunogenicity ,Clinical Biochemistry ,Oligonucleotides ,General Medicine ,Computational biology ,Flow Cytometry ,Chemistry Techniques, Analytical ,Mass Spectrometry ,Analytical Chemistry ,Social Control, Formal ,Medical Laboratory Technology ,Indicators and Reagents ,Business ,General Pharmacology, Toxicology and Pharmaceutics - Abstract
The 12th GCC Closed Forum was held in Philadelphia, PA, USA, on 9 April 2018. Representatives from international bioanalytical Contract Research Organizations were in attendance in order to discuss scientific and regulatory issues specific to bioanalysis. The issues discussed at the meeting included: critical reagents; oligonucleotides; certificates of analysis; method transfer; high resolution mass spectrometry; flow cytometry; recent regulatory findings and case studies involving stability and nonclinical immunogenicity. Conclusions and consensus from discussions of these topics are included in this article.
- Published
- 2019
115. Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis
- Author
-
Mathilde Yu, Michele Malone, John Stamatopoulos, Christina Satterwhite, George Hristopoulos, Simona Rizea Savu, Mohammed Bouhajib, Chad Briscoe, Edward Tabler, Philippe Couerbe, Edward Wells, Ardeshir Khadang, Ira DuBey, Sian Estdale, Mark Warren, Hanna Ritzén, Wei Garofolo, Franklin Spriggs, Arron Xu, Chris Beaver, Jennifer Zimmer, Iohann Boulay, Anahita Keyhani, Kayode Awaiye, Vellalore Kakkanaiah, Curtis Sheldon, Jessica St Charles, Roger Hayes, Patrick Bennett, James Bourdage, Yi Qun Xiao, Marc Moussallie, Sumit Kar, Shane Karnik, Rabab Tayyem, Maria Cruz Caturla, Clark V. Williard, Hao Wang, Nadia Kulagina, Nicola Hughes, Robert MacNeill, Luigi DiMarco, Andrew Dinan, Kathie Lindley, Natasha Savoie, Xinping Fang, Chantal DiMarco, Bruce Stouffer, Jenifer Vija, Corey Nehls, Stephanie Cape, Eric Thomas, John Lindsay, Paul Rhyne, Michael E. Brown, Jenny Lin, Amanda Hays, Allan Xu, Hao Feng, Lawrence Goodwin, Rafiq Islam, Colin Barry, and Dave Williams
- Subjects
Quality Control ,Bioanalysis ,Societies, Pharmaceutical ,Clinical Biochemistry ,Commercial kit ,Ligands ,030226 pharmacology & pharmacy ,01 natural sciences ,Analytical Chemistry ,03 medical and health sciences ,0302 clinical medicine ,White paper ,Surveys and Questionnaires ,Drug Discovery ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,health care economics and organizations ,End user ,010401 analytical chemistry ,General Medicine ,Reference Standards ,0104 chemical sciences ,Medical Laboratory Technology ,Engineering management ,ComputingMethodologies_PATTERNRECOGNITION ,Contract research organization ,Drug development ,Pharmaceutical Preparations ,Biomarker (medicine) ,Biological Assay ,Business ,Reagent Kits, Diagnostic ,Biomarkers - Abstract
Over the last decade, the use of biomarker data has become integral to drug development. Biomarkers are not only utilized for internal decision-making by sponsors; they are increasingly utilized to make critical decisions for drug safety and efficacy. As the regulatory agencies are routinely making decisions based on biomarker data, there has been significant scrutiny on the validation of biomarker methods. Contract research organizations regularly use commercially available immunoassay kits to validate biomarker methods. However, adaptation of such kits in a regulated environment presents significant challenges and was one of the key topics discussed during the 12th Global Contract Research Organization Council for Bioanalysis (GCC) meeting. This White Paper reports the GCC members’ opinion on the challenges facing the industry and the GCC recommendations on the classification of commercial kits that can be a win-win for commercial kit vendors and end users.
- Published
- 2019
116. The Benefits and Challenges of Conducting Field Experiments in Consumer Research
- Author
-
Nicholas Prew and Meng-Hsien (Jenny) Lin
- Subjects
Architectural engineering ,Field (Bourdieu) ,Consumer research ,Psychology - Published
- 2019
117. Emergent high fatality lung disease in systemic juvenile arthritis
- Author
-
Jenny Lin, Michal Cidon, Richard K. Vehe, Seza Ozen, Aliva De, Christi J. Inman, Suhas M. Radhakrishna, Maria Ibarra, Fabrizio De Benedetti, Raymond R. Balise, Joy Mombourquette, James Birmingham, Maria de los Angeles Ceregido Perez, Ian Ferguson, Marisa Klein-Gitelman, Steven I. Goodman, Layla Bouzoubaa, Karen Onel, Assunta Ho, Khanh Lai, Kathleen A. Haines, Sara O. Vargas, Ann N. Leung, Dieneke Schonenberg-Meinema, Sampath Prahalad, Rayfel Schneider, R. Paul Guillerman, Gail H. Deutsch, Kevin W. Baszis, Alicia Casey, Deborah R. Liptzin, Lu Tian, Vivian E. Saper, Adam L Reinhardt, Grant S. Schulert, Diana Milojevic, Martha P. Fishman, Lauren A. Henderson, Purvesh Khatri, Johannes Roth, Edward M. Behrens, Mona Riskalla, Gill Bejerano, Jacqueline Yang, Clara Lin, Sivia K. Lapidus, Alexei A. Grom, Elizabeth D. Mellins, Matthew L. Stoll, Mark M. Davis, Randy Q. Cron, Karthik A. Jagadeesh, Khalid Abulaban, Khulood Khawaja, Natalie Rosenwasser, Kathryn Phillippi, Hafize Emine Sönmez, Ying Lu, Lisa R. Young, T Brent Graham, Rita Jerath, Daniel J. Kingsbury, Guangbo Chen, Melissa M. Hazen, Robin R. Deterding, Scott W. Canna, Christopher Towe, Johannes Birgmeier, Judith A. Smith, Susan Shenoi, Jianpeng Xu, Tushar J. Desai, Graduate School, Paediatric Infectious Diseases / Rheumatology / Immunology, and AII - Inflammatory diseases
- Subjects
Lung Diseases ,Male ,0301 basic medicine ,medicine.medical_specialty ,Biopsy ,Immunology ,Arthritis ,Gastroenterology ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tocilizumab ,Rheumatology ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Child ,Lung ,Pathological ,Retrospective Studies ,030203 arthritis & rheumatology ,business.industry ,Incidence ,Infant ,Retrospective cohort study ,Prognosis ,medicine.disease ,Arthritis, Juvenile ,United States ,Survival Rate ,030104 developmental biology ,chemistry ,Child, Preschool ,Concomitant ,Macrophage activation syndrome ,Female ,Tomography, X-Ray Computed ,Trisomy ,Pulmonary alveolar proteinosis ,business ,Follow-Up Studies - Abstract
ObjectiveTo investigate the characteristics and risk factors of a novel parenchymal lung disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA).MethodsIn a multicentre retrospective study, 61 cases were investigated using physician-reported clinical information and centralised analyses of radiological, pathological and genetic data.ResultsLD was associated with distinctive features, including acute erythematous clubbing and a high frequency of anaphylactic reactions to the interleukin (IL)-6 inhibitor, tocilizumab. Serum ferritin elevation and/or significant lymphopaenia preceded LD detection. The most prevalent chest CT pattern was septal thickening, involving the periphery of multiple lobes ± ground-glass opacities. The predominant pathology (23 of 36) was pulmonary alveolar proteinosis and/or endogenous lipoid pneumonia (PAP/ELP), with atypical features including regional involvement and concomitant vascular changes. Apparent severe delayed drug hypersensitivity occurred in some cases. The 5-year survival was 42%. Whole exome sequencing (20 of 61) did not identify a novel monogenic defect or likely causal PAP-related or macrophage activation syndrome (MAS)-related mutations. Trisomy 21 and young sJIA onset increased LD risk. Exposure to IL-1 and IL-6 inhibitors (46 of 61) was associated with multiple LD features. By several indicators, severity of sJIA was comparable in drug-exposed subjects and published sJIA cohorts. MAS at sJIA onset was increased in the drug-exposed, but was not associated with LD features.ConclusionsA rare, life-threatening lung disease in sJIA is defined by a constellation of unusual clinical characteristics. The pathology, a PAP/ELP variant, suggests macrophage dysfunction. Inhibitor exposure may promote LD, independent of sJIA severity, in a small subset of treated patients. Treatment/prevention strategies are needed.
- Published
- 2019
118. Above Sea
- Author
-
Jenny Lin
- Abstract
Shanghai, long known as mainland China’s most cosmopolitan metropolis, has recently re-emerged as a global capital. Above sea: Contemporary art, urban culture, and the fashioning of global Shanghai offers the first in-depth examination of turn of the twenty-first century Shanghai-based art and design – from state-sponsored exhibitions to fashionable cultural complexes to cutting edge films and installations. This book offers a counter-touristic view of one of the world’s fastest developing megacities that penetrates the contradictions and buried layers of specific locales and artifacts of visual culture. Informed by years of in-situ research including interviews with artists and designers, the book looks beyond contemporary art’s global hype to reveal persistent socio-political tensions accompanying Shanghai’s explosive transitions from semi-colonial capitalism to Maoist socialism to Communist Party-sponsored capitalism. Analyses of exemplary design projects such as Xintiandi and Shanghai Tang, and artworks by Liu Jianhua, Yang Fudong, Gu Wenda and more reveal how Shanghai’s global aesthetics construct glamorizing artifices that mask historically-rooted cross-cultural conflicts between vying notions of foreign-influenced modernity versus anti-colonialist nationalism, and the city’s repressed socialist past versus consumerist present. The book focuses on Shanghai-based art and design from the 1990s-2000s, the decades of the city’s most rapid post-socialist development, while also attending to pivotal Republican and Mao Era examples. Challenging the “East-meets-West” clichés that characterize discussions of urban Shanghai and contemporary Chinese art, this book illuminates critical issues facing today’s artists, architects, and designers, and provides an essential field guide for students of art, design, art history, urban studies, and Chinese culture.
- Published
- 2019
119. Shanghai’s art in fashion
- Author
-
Jenny Lin
- Abstract
Chapter Two considers how Shanghai Tang, a Hong Kong-founded fashion brand, exploits Shanghai’s imagined cosmopolitan legacy towards the building of a multinational luxury brand. The author considers the rising political tensions between Hong Kong and Shanghai, as Hong Kong was handed over from British to mainland Chinese rule in 1997. The chapter discusses a 1997 Shanghai Tang advertisement featuring Chinese actress Gong Li, addressing how the image signals the return of class-based society, while sanitizing mainland China’s immediate socialist past. This chapter also examines the powerful influence of Shanghai Tang’s founder, art collector Sir David Tang, on the international dissemination of contemporary Chinese art, exploring key Shanghainese painters promoted by Tang, including Yu Youhan, Wang Ziwei and Ding Yi. Referencing these artists’ connections to Shanghai Tang, and also the French fashion brand, Christian Dior, the chapter theorizes the rise of a contemporary Chinese art/fashion system. The final section focuses on Shanghai-based sculptor Liu Jianhua, who has been supported by both Tang and Christian Dior, and the artist’s subversion of mainland China’s presumed role as “the factory of the world” through his ceramic-based practice.
- Published
- 2019
120. From the ruins of heaven on earth
- Author
-
Jenny Lin
- Subjects
media_common.quotation_subject ,Economics ,Heaven ,Earth (chemistry) ,Astrobiology ,media_common - Abstract
Chapter One examines pastiche in the shopping mall and cultural heritage site Xintiandi, before discussing the site’s buried modern art histories marred by cross-cultural conflicts. Xintiandi physically surrounds China’s first communist meeting site of 1921, today memorialized as a museum. The complex was designed with reference to the vernacular homes of its formerly foreign occupied French Concession setting, and is officially celebrated for its “East-meets-West” and “Old-meets-New” architecture, even while the construction demolished most of the site’s existing homes and dislocated thousands of working class residents. This chapter analyzes how Xintiandi’s seemingly benign East-meets-West façades mask collusions between the Chinese Communist Party’s autocratic state power and capitalist development, while romanticizing Shanghai’s modern cosmopolitan legacy. The chapter analyzes examples of Xintiandi’s repressed cultural histories, including the revolutionary art and design experiments of Pang Xunqin, founder of the 1930s avant-garde collective, The Storm Society, leftist writings and art promoted by Lu Xun, and the major Cultural Revolution Era debate sparked by Michelangelo Antonioni’s 1972 documentary, Chung Kuo Cina. The chapter argues that the official admonishment of Shanghai-based cultural projects by Pang and Antonioni speak to collisions between Shanghai’s semi-colonial past, Maoist socialism, and Cultural Revolution Era totalitarianism that still resonate in Shanghai today.
- Published
- 2019
121. Affektiv polarisering i Norden – en oversikt
- Author
-
Erik Knudsen, Jenny Lindholm, Lene Heiselberg, and Nils Holmberg
- Subjects
Social sciences (General) ,H1-99 - Published
- 2023
- Full Text
- View/download PDF
122. Above Sea : Contemporary Art, Urban Culture, and the Fashioning of Global Shanghai
- Author
-
Jenny Lin and Jenny Lin
- Subjects
- Popular culture--China--Shanghai, Arts--China--Shanghai, Art and society--China--Shanghai, Fashion--China--Shanghai--History--20th century
- Abstract
Shanghai, long known as mainland China's most cosmopolitan city, is today a global cultural capital. This book offers the first in-depth examination of contemporary Shanghai-based art and design – from state-sponsored exhibitions to fashionable cultural complexes to cutting edge films and installations. Informed by years of in-situ research, the book looks beyond contemporary art's global hype to reveal the socio-political tensions accompanying Shanghai's transitions from semi-colonial capitalism to Maoist socialism to Communist Party-sponsored capitalism. Case studies reveal how Shanghai's global aesthetic constructs glamorising artifices that mask the conflicts between vying notions of foreign-influenced modernity and anti-colonialist nationalism, as well as the city's repressed socialist past and its consumerist present.
- Published
- 2019
123. Electrodiagnostic Abnormalities in Tick Paralysis
- Author
-
Sumit Verma and Jenny Lin
- Subjects
Pathology ,medicine.medical_specialty ,Proximal muscle weakness ,Neural Conduction ,Action Potentials ,Motor nerve ,Electromyography ,030204 cardiovascular system & hematology ,Tick paralysis ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Child ,Muscle, Skeletal ,Muscle Weakness ,medicine.diagnostic_test ,Orbicularis oculi muscle ,business.industry ,Electrodiagnosis ,Muscle weakness ,Skeletal muscle ,General Medicine ,medicine.disease ,Tick Paralysis ,Compound muscle action potential ,medicine.anatomical_structure ,Neurology ,Anesthesia ,Female ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Objective To study the electrodiagnostic abnormalities in tick paralysis. Methods A 7-year-old girl with acute onset proximal muscle weakness and an engorged dog tick attached to her scalp was evaluated. Results The routine motor nerve conduction study showed normal compound muscle action potential amplitude. The stimulated jitter analysis of the orbicularis oculi muscle showed normal jitter with no blocking. The quantitative electromyography of the proximal muscles showed decreased mean duration of the motor unit potentials. Conclusion We propose toxin-mediated direct skeletal muscle involvement as one of the reasons for muscle weakness in tick paralysis.
- Published
- 2016
124. Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3
- Author
-
Jenny Lin, Rahul Jandial, Mike Y. Chen, Yufang Yin, Li-chen J. Hsu, Richard Jove, Zhaoxia Zou, Fan Yang, Vanessa L. Brandon, and Gang Li
- Subjects
Niacinamide ,STAT3 Transcription Factor ,Transcriptional Activation ,0301 basic medicine ,Sorafenib ,Programmed cell death ,Pathology ,medicine.medical_specialty ,Melanoma, Experimental ,Antineoplastic Agents ,Convection ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,medicine ,Animals ,Humans ,STAT3 ,neoplasms ,biology ,Brain Neoplasms ,business.industry ,Phenylurea Compounds ,Melanoma ,General Medicine ,medicine.disease ,Mice, Inbred C57BL ,030104 developmental biology ,Apoptosis ,Tumor progression ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Systemic administration ,STAT protein ,Heterografts ,business ,Neoplasm Transplantation ,medicine.drug - Abstract
OBJECT Despite recent advances, metastatic melanoma remains a terminal disease, in which life-threatening brain metastasis occurs in approximately half of patients. Sorafenib is a multikinase inhibitor that induces apoptosis of melanoma cells in vitro. However, systemic administration has been ineffective because adequate tissue concentrations cannot be achieved. This study investigated if convection-enhanced delivery (CED) of sorafenib would enhance tumor control and survival via inhibition of the signal transducer and activator of transcription 3 (Stat3) pathway in a murine model of metastatic brain melanoma. METHODS Melanoma cells treated with sorafenib in vitro were examined for signaling and survival changes. The effect of sorafenib given by CED was assessed by bioluminescent imaging and animal survival. RESULTS The results showed that sorafenib induced cell death in the 4 established melanoma cell lines and in 1 primary cultured melanoma cell line. Sorafenib inhibited Stat3 phosphorylation in HTB65, WYC1, and B16 cells. Accordingly, sorafenib treatment also decreased expression of Mcl-1 mRNA in melanoma cell lines. Because sorafenib targets multiple pathways, the present study demonstrated the contribution of the Stat3 pathway by showing that mouse embryonic fibroblast (MEF) Stat3 +/+ cells were significantly more sensitive to sorafenib than MEF Stat3 −/− cells. In the murine model of melanoma brain metastasis used in this study, CED of sorafenib increased survival by 150% in the treatment group compared with animals receiving the vehicle control (p < 0.01). CED of sorafenib also significantly abrogated tumor growth. CONCLUSIONS The data from this study indicate that local delivery of sorafenib effectively controls brain melanoma. These findings validate further investigation of the use of CED to distribute molecularly targeted agents.
- Published
- 2016
125. 9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks
- Author
-
Ardeshir Khadang, Elizabeth Groeber, Gunjan Soni, Yi Qun Xiao, Afshin Safavi, Saadya Fatmi, Manon Verville, Daniel Mulvana, Gene Ray, Sarah Harris, Mathilde Yu, Allan Xu, Jenny Lin, Isabelle Dumont, Clare Kingsley, Mike Buonarati, Nico C van de Merbel, Masood Khan, Natasha Savoie, Ian Ward, Luigi Silvestro, Michele Fiscella, Nadine Boudreau, Curtis Sheldon, Jaap Wieling, Richard LeLacheur, Christina Satterwhite, Benno Ingelse, Anahita Keyhani, Shane Karnik, Kai Kurylak, Ann Lévesque, Roger Hayes, Bob Nicholson, Rafiq Islam, Mike Allen, Jennifer Zimmer, Edward Tabler, Philippe Couerbe, Colin Pattison, Xinping Fang, Lorella Di Donato, Zhongping John Lin, Mario Rocci, Manju Saxena, Yansheng Liu, Ron Shoup, Patrick Bennett, Wei Garofolo, Laura Cojocaru, Stephanie Cape, Maria Cruz Caturla, Nicola Hughes, Jennifer Bravo, James Bourdage, Michele Malone, Chad Briscoe, James Hulse, Hanna Ritzén, and Mohammed Bouhajib
- Subjects
Bioanalysis ,Medical education ,Best practice ,010401 analytical chemistry ,Clinical Biochemistry ,Biosimilar ,General Medicine ,Audit ,Bioinformatics ,030226 pharmacology & pharmacy ,01 natural sciences ,0104 chemical sciences ,Analytical Chemistry ,03 medical and health sciences ,Medical Laboratory Technology ,0302 clinical medicine ,Business ,General Pharmacology, Toxicology and Pharmaceutics - Abstract
The 9th GCCClosed Forum was held just prior to the 2015 Workshop on Recent Issues in Bioanalysis (WRIB) in Miami, FL, USA on 13 April 2015. In attendance were 58 senior-level participants, from eight countries, representing 38 CRO companies offering bioanalytical services. The objective of this meeting was for CRO bioanalytical representatives to meet and discuss scientific and regulatory issues specific to bioanalysis. The issues selected at this year's closed forum include CAPA, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, and ELNs. A summary of the industry's best practices and the conclusions from the discussion of these topics is included in this meeting report.
- Published
- 2016
126. Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team
- Author
-
Thales Cardoso, Mohamed Ben M’Barek, Jenny Lin, Lisa Geisler, Harue Igarashi, Jay Schaefgen, Subramanian Ramachandran, Vera Hillewaert, and Michael J. Redrup
- Subjects
Protocol (science) ,Internationality ,Process management ,Operations research ,Computer science ,010401 analytical chemistry ,Pharmaceutical Science ,Sample (statistics) ,Congresses as Topic ,01 natural sciences ,Specimen Handling ,0104 chemical sciences ,Unique identifier ,03 medical and health sciences ,Management information systems ,0302 clinical medicine ,Documentation ,030220 oncology & carcinogenesis ,Medical Laboratory Science ,Commentary ,Humans ,Electronic data ,Sample collection ,Biological Specimen Banks ,Chain of custody - Abstract
The importance of appropriate sample management in regulated bioanalysis is undeniable for clinical and non-clinical study support due to the fact that if the samples are compromised at any stage prior to analysis, the study results may be affected. Health authority regulations do not contain specific guidance on sample management; therefore, as part of the Global Bioanalysis Consortium (GBC), the A5 team was established to discuss sample management requirements and to put forward recommendations. The recommendations from the team concern the entire life span of the sample and include the following: 1. Sampling procedures should be described in the protocol or within the laboratory manual. This information should include the volume of the sample to be collected, the required anticoagulant, light sensitivity, collection and storage containers, and labeling with a unique identifier. 2. The correct procedures for processing and then storing the samples after collection at the clinical/non-clinical testing site and during shipment are also very important to ensure the analyte(s) stability and should be documented. 3. Chain of custody for the samples must be maintained throughout the complete life span of each sample. This is typically maintained via paper and electronic data systems, including Laboratory Information Management Systems (LIMS) where available. 4. Pre- and post-analysis storage location and conditions must also be clearly defined at the analytical laboratory. The storage temperature of the samples must be traceable and controlled by monitoring and warning alerts. The team suggests moving away from using temperatures and to adopt standard terminology of "room temperature," "refrigerator," "freezer," and "ultra-freezer" that have defined and industry-wide accepted temperature ranges. 5. At the end of the study, documentation of the samples' disposal is required.
- Published
- 2016
127. Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer
- Author
-
Amanda Nesbit, Mike Y. Chen, Leanne Goldstein, and Jenny Lin
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,business.industry ,Estrogen receptor ,Bone metastasis ,medicine.disease ,Spinal column ,Cancer registry ,Lesion ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Breast cancer ,Hormone receptor ,030220 oncology & carcinogenesis ,Progesterone receptor ,medicine ,Surgery ,Neurology (clinical) ,medicine.symptom ,business - Abstract
Objective Bony metastasis predominantly affects the spinal column and has been commonly associated in patients with breast cancer. There are two types of lesions that can occur with spine cancer—osteolytic or osteoblastic. Some patients may have mixed lesions, which include lytic and blastic in one vertebra or lytic and blastic in different vertebrae. Previous studies have shown that patients with breast cancer have an increased likelihood for development of lytic spinal metastases. Methods A retrospective chart review was conducted to more closely examine the association between hormone receptor status and spinal lesion type. A total of 195 patients were initially identified through the City of Hope Cancer Registry. Of the 195, only 153 patients had hormone receptor marker status available. Associations between spinal lesion and hormone receptor status were evaluated using χ 2 tests with alpha = 0.05 significance level. In a secondary analysis, the Oncomine Platform was used, which integrated The Cancer Genome Atlas (TCGA) datasets, to identify osteogenic genes that may be relevant to invasive breast cancers. Results Contrary to previous studies, our findings revealed progesterone receptor positive (PR+) patients were significantly more likely to present with blastic than lytic or mixed lesions. Furthermore, using TCGA analysis, COL1A1 and COL1A2 were found to be up-regulated, which could provide a molecular explanation for the development of blastic metastases. Conclusions By integrating clinical and bioinformatic techniques, this study provides a novel discovery of the relationship between blastic and PR + breast cancers, which may have important implications for diagnostic strategies concerning vertebral metastases.
- Published
- 2016
128. Plates
- Author
-
Jenny Lin
- Published
- 2018
129. Bibliography
- Author
-
Jenny Lin
- Published
- 2018
130. Index
- Author
-
Jenny Lin
- Published
- 2018
131. Contents
- Author
-
Jenny Lin
- Published
- 2018
132. Epilogue
- Author
-
Jenny Lin
- Published
- 2018
133. Above sea
- Author
-
Jenny Lin
- Published
- 2018
134. Front matter
- Author
-
Jenny Lin
- Published
- 2018
135. Acknowledgments
- Author
-
Jenny Lin
- Published
- 2018
136. Dedication
- Author
-
Jenny Lin
- Published
- 2018
137. Glossary
- Author
-
Jenny Lin
- Published
- 2018
138. Installing a world city
- Author
-
Jenny Lin
- Subjects
Architectural engineering ,Engineering ,business.industry ,business - Abstract
Chapter Four considers worlding, or the city’s positioning as a cosmopolitan center on an international stage, as a philosophical construct and tangible phenomenon tied to the development and promotion of present-day Shanghai and contemporary Chinese art. The chapter presents three Shanghai-based installations by transnational art stars Gu Wenda, Xu Bing, and Cai Guoqiang. Disrupting the East-meets-West soundbites surrounding discussions of these works, this chapter interrogates the artists’ privileged subject positions, arguing that such artworks function as branding campaigns that world Shanghai. The chapter also discusses the loaded cultural geographies of these installations’ shared sites: the Bund, once the heart of Shanghai’s British and US-controlled International Settlement, and the Pudong Skyline, considered the shining jewel of China’s post-socialist economic rise. The chapter concludes by discussing a more critical recent project by Cai Guoqiang that acknowledged the migrant labor fuelling Shanghai’s urbanization in the face of the 2010 Shanghai World Expo, and a related urban intervention by artist Ai Weiwei.
- Published
- 2018
139. Notes on Chinese-to-English translations
- Author
-
Jenny Lin
- Published
- 2018
140. List of ilustrations
- Author
-
Jenny Lin
- Published
- 2018
141. Beyond East-meets-West
- Author
-
Jenny Lin
- Subjects
Exhibition ,Globalization ,History ,business.industry ,Aesthetics ,Chinese art ,Mythology ,business ,China ,Everyday life ,Fine art ,Contemporary art - Abstract
Many contemporary Chinese artists have proposed and created projects in Shanghai that imagine – in both celebratory and critical ways – the city’s historically rooted “East-meets-West” mythology. This chapter analyzes key case studies by three of China’s most internationally known artists: Gu Wenda’s art proposal Heavenly Lantern Project for Shanghai (2003–ongoing), which utilizes cross-cultural content, aesthetic motifs, and conceptual tropes to celebrate East-meets-West Shanghai; Liu Jianhua’s photographic series The Virtual Scene (2005) and exhibition Export – Cargo Transit (2007), which question Shanghai’s urbanization and highlight the negative impacts of globalization and uneven East–West relations; and Yang Fudong’s photographic triptych The First Intellectual (2000) and film installation Seven Intellectuals in a Bamboo Forest (2003–2007), which critique Shanghai’s romanticized mythology and expose current conflicts facing the city’s artists and intellectuals. My analyses aim to disrupt common assumptions underlying recent discussions of urban Shanghai and contemporary Chinese art: that both city and category effortlessly transcend national borders and cultural divides, operating through harmonious East-meets-West encounters. I argue that Gu’s celebratory proposal and critical projects by Liu and Yang construct urban imaginaries that speak less to Shanghai’s East-meets-West status or the seamless integration of diverse cultures and fluid insertion of Chinese art into the Euro-American-dominated canon of contemporary art, and more to the mistranslations, social alienations, and merging of fine art and commodity culture that belie contemporary Chinese art and everyday life in Shanghai.
- Published
- 2018
142. Association Between Periodic Limb Movements in Sleep and Cerebrovascular Changes in Children With Sickle Cell Disease
- Author
-
Jenny Lin, Katharina D. Graw-Panzer, Keivan Shifteh, Rina Chernin, Deepa Manwani, Kerry Morrone, Raanan Arens, Sanghun Sin, and Ellen J. Silver
- Subjects
Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Adolescent ,Ultrasonography, Doppler, Transcranial ,Polysomnography ,Disease ,Anemia, Sickle Cell ,Constriction, Pathologic ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Medicine ,Humans ,Association (psychology) ,Child ,Stroke ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Brain ,Magnetic resonance imaging ,medicine.disease ,Sleep in non-human animals ,Magnetic Resonance Imaging ,Scientific Investigations ,Transcranial Doppler ,Nocturnal Myoclonus Syndrome ,Cerebrovascular Disorders ,Increased risk ,Neurology ,Child, Preschool ,Cardiology ,Female ,Neurology (clinical) ,Moyamoya Disease ,business ,030217 neurology & neurosurgery - Abstract
STUDY OBJECTIVES: Periodic limb movements (PLMs) have been associated with increased risk of stroke, but there is currently scarce research exploring this relationship in the setting of sickle cell disease (SCD). The aim of this study was to explore whether increased PLMs in children with SCD are associated with increased risk of cerebrovascular disease and to determine if there are any clinical or laboratory differences between children with SCD with elevated periodic limb movement index (PLMI) versus those with normal PLMI. METHODS: This study is a comprehensive review of medical records of 129 children with SCD (aged ≤ 18 years) who had undergone polysomnography for evaluation of sleep-disordered breathing. RESULTS: Elevated PLMI (PLMI > 5 events/h) was present in 42% (54/129) of children with SCD. Children with elevated PLMI were found to have higher percentage of hemoglobin S, lower total iron, higher arousal index and tendency toward elevated transcranial Doppler velocity (P = .063, odds ratio = 3.9, 95% CI 0.93–16.22). While association between elevated PLMI and isolated cerebrovascular stenosis (P = .050, odds ratio 5.6, 95% CI 1.0–31.10) trended toward significance, there was significantly greater proportion of children with elevated PLMI who had cerebrovascular stenosis with Moyamoya disease (P = .046) as demonstrated by magnetic resonance imaging (MRI). CONCLUSIONS: The prevalence of elevated PLMI in children with SCD was higher than in previously published data. Elevated PLMI was significantly associated with greater rates of cerebrovascular disease as detected by MRI. CITATION: Lin J, Morrone K, Manwani D, Chernin R, Silver EJ, Shifteh K, Sin S, Arens R, Graw-Panzer K. Association between periodic limb movements in sleep and cerebrovascular changes in children with sickle cell disease. J Clin Sleep Med. 2019;15(7):1011–1019.
- Published
- 2018
143. Individual differences in the impact of odor-induced emotions on consumer behavior
- Author
-
Meng-Hsien Jenny Lin
- Subjects
Conceptual framework ,Odor ,Sensory marketing ,Olfaction ,Psychology ,Social psychology ,Consumer behaviour ,Mental image ,Cognitive psychology - Abstract
iv CHAPTER 1: INTRODUCTION 1 CHAPTER 2: LITERATURE REVIEW AND HYPOTHESES 13 Literature review 13 Olfaction 13 Emotions 26 Research framework 31 Hypotheses 33 CHAPTER 3: MATERIALS AND METHODS 40 Overview of studies 40 Experiment 1: Odor-elicited emotions 41 Experiment 2: Emotions-elicited in odor-associated images and olfactory mental imagery .. 45 Experiment 3: The “contagion effects” of odors on judgment and decision making 48 Experiment 4: Are emotions enhanced by smell cues in ads? 54 Data analyses 57 CHAPTER 4: RESULTS 59 Experiment 1: Odor-elicited emotions 60 Experiment 2: Emotions-elicited in odor-associated images and olfactory mental imagery .. 65 Experiment 3: The “contagion effects” of odors on judgment and decision making 68 Experiment 4: Are emotions enhanced by smell cues in ads? 84 CHAPTER 5: DISCUSSION 99
- Published
- 2018
144. 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation
- Author
-
Franklin Spriggs, Chris Beaver, Ashley Brant, Daniel Sikkema, Susan Ohorodnik, John Lindsay, Wei Garofolo, Mike Buonarati, Jing Tu, Chad Briscoe, Scott Fountain, James Hulse, Andrew Dinan, Mark E. Arnold, Rafiq Islam, Saadya Fatmi, James Bourdage, Michael E. Brown, Jim Wilfahrt, Edward Tabler, Philippe Couerbe, Anahita Keyhani, Roger Hayes, Ariana Tudoroniu, Adriana Iordachescu, Kelly Colletti, Jennifer Zemo, Natasha Savoie, Jessica St Charles, John Stamatopoulos, Damon Papac, Colin Barry, Vimal Patel, Gene Ray, Bruce Stouffer, John Marcelletti, Jenny Lin, Jennifer Zimmer, Mark Warren, Mathilde Yu, Maria Cruz Caturla, Philip Joyce, Jenifer Vija, Christina Sanchez, Rachel Green, Xinping Fang, Clark V. Williard, Yansheng Liu, Mohammed Bouhajib, Stephanie Cape, Ira DuBey, Masood Khan, George Hristopoulos, Nicola Hughes, Nadine Boudreau, Barry van der Strate, Rabab Tayyem, Jim Datin, Michael Kennedy, Joanne Hayward-Sewell, Edward Wells, Joseph Bower, Christina Satterwhite, Yi Qun Xiao, Jim Yamashita, Corey Nehls, Curtis Sheldon, Dominic Warrino, Allan Xu, Shane Karnik, and Ardeshir Khadang
- Subjects
Bioanalysis ,China ,Computer science ,Matrix stability ,010401 analytical chemistry ,Clinical Biochemistry ,Biosimilar ,General Medicine ,030226 pharmacology & pharmacy ,01 natural sciences ,0104 chemical sciences ,Analytical Chemistry ,Food and drug administration ,03 medical and health sciences ,Medical Laboratory Technology ,Engineering management ,0302 clinical medicine ,Research Design ,Humans ,Biological Assay ,Sample collection ,General Pharmacology, Toxicology and Pharmaceutics ,Laboratory Manuals ,Biosimilar Pharmaceuticals ,Biomarkers - Abstract
The 11th Global CRO Council Closed Forum was held in Universal City, CA, USA on 3 April 2017. Representatives from international CRO members offering bioanalytical services were in attendance in order to discuss scientific and regulatory issues specific to bioanalysis. The second CRO–Pharma Scientific Interchange Meeting was held on 7 April 2017, which included Pharma representatives’ sharing perspectives on the topics discussed earlier in the week with the CRO members. The issues discussed at the meetings included cumulative stability evaluations, matrix stability evaluations, the 2016 US FDA Immunogenicity Guidance and recent and unexpected FDA Form 483s on immunogenicity assays, the bioanalytical laboratory's role in writing PK sample collection instructions, biosimilars, CRO perspectives on the use of chiral versus achiral methods, hybrid LBA/LCMS assays, applications of fit-for-purpose validation and, at the Global CRO Council Closed Forum only, the status and trend of current regulated bioanalytical practice in China under CFDA's new BMV policy. Conclusions from discussions of these topics at both meetings are included in this report.
- Published
- 2018
145. 448 Clinical outcomes and safety of immune checkpoint inhibitors (ICI) in patients with solid tumors and paraneoplastic syndromes (PNS)
- Author
-
Lucia Kwak, So Yeon Kim, Elad Sharon, Abdul Rafeh Naqash, Alessio Cortellini, Toni K Choueiri, Rana Mckay, Jeffrey A Sparks, Kaushal Parikh, Frank Aboubakar Nana, Jenny Linnoila, Shruti Gupta, Nicole R LeBoeuf, Elio Adib, Amin Nassar, Talal El Zarif, Ahmed Bilal Khalid, Serena J Rahme, Marita Salame, Elias Bou Farhat, Edward El Am, Arjun Ravishankar, Bachar Ahmad, David Kaldas, Andrea Malgeri, Ole-Petter R Hamnvik, Thomas Dilling, Elie Najem, and Guru P Sonpavde
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2023
- Full Text
- View/download PDF
146. Online Information Processing of Scent-Related Words and Implications for Decision Making
- Author
-
Meng-Hsien (Jenny) Lin, Samantha N.N. Cross, Terry L. Childers, and William J. Jones
- Subjects
Decision engineering ,business.industry ,Information processing ,Context (language use) ,Cognition ,computer.software_genre ,Online advertising ,R-CAST ,Management information systems ,Market segmentation ,Artificial intelligence ,business ,Psychology ,computer ,Natural language processing ,Cognitive psychology - Abstract
This paper takes a multi-method approach, combining neuroscience methods and behavioral experiments to investigate emotions triggered by olfactory-related information and related consumer decision-making outcomes. In the online context, olfactory information is limited to visual forms of triggering olfactory sensations. The effectiveness of using sensory congruent brand names in online ads to trigger emotions, and the influence on attitudes toward the ad, brand and purchase intentions are examined. Moreover, individual differences in olfactory sensitivity were considered, revealing moderating effects on cognitive and emotional processes. Findings provide managerial and organizational implications for online advertising, branding decisions and market segmentation decisions.
- Published
- 2017
147. Jenny Lin. Review of 'Van Gogh on Demand: China and the Readymade' by Winnie Won Yin Wong
- Author
-
Jenny Lin
- Subjects
History ,Complementary and alternative medicine ,On demand ,Pharmaceutical Science ,Art history ,Pharmacology (medical) ,Performance art ,China - Published
- 2017
148. Configurable 3D Scene Synthesis and 2D Image Rendering with Per-Pixel Ground Truth using Stochastic Grammars
- Author
-
Demetri Terzopoulos, Chenfanfu Jiang, Jenny Lin, Siyuan Qi, Lap-Fai Yu, Siyuan Huang, Song-Chun Zhu, and Yixin Zhu
- Subjects
FOS: Computer and information sciences ,Computer Vision and Pattern Recognition (cs.CV) ,Computer Science - Computer Vision and Pattern Recognition ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Machine Learning (stat.ML) ,02 engineering and technology ,Rendering (computer graphics) ,Statistics - Machine Learning ,Artificial Intelligence ,Stochastic grammar ,0202 electrical engineering, electronic engineering, information engineering ,Computer vision ,ComputingMethodologies_COMPUTERGRAPHICS ,Ground truth ,Pixel ,business.industry ,020207 software engineering ,Object (computer science) ,Pipeline (software) ,Pattern recognition (psychology) ,Graph (abstract data type) ,020201 artificial intelligence & image processing ,Computer Vision and Pattern Recognition ,Artificial intelligence ,business ,Software - Abstract
We propose a systematic learning-based approach to the generation of massive quantities of synthetic 3D scenes and arbitrary numbers of photorealistic 2D images thereof, with associated ground truth information, for the purposes of training, benchmarking, and diagnosing learning-based computer vision and robotics algorithms. In particular, we devise a learning-based pipeline of algorithms capable of automatically generating and rendering a potentially infinite variety of indoor scenes by using a stochastic grammar, represented as an attributed Spatial And-Or Graph, in conjunction with state-of-the-art physics-based rendering. Our pipeline is capable of synthesizing scene layouts with high diversity, and it is configurable inasmuch as it enables the precise customization and control of important attributes of the generated scenes. It renders photorealistic RGB images of the generated scenes while automatically synthesizing detailed, per-pixel ground truth data, including visible surface depth and normal, object identity, and material information (detailed to object parts), as well as environments (e.g., illuminations and camera viewpoints). We demonstrate the value of our synthesized dataset, by improving performance in certain machine-learning-based scene understanding tasks--depth and surface normal prediction, semantic segmentation, reconstruction, etc.--and by providing benchmarks for and diagnostics of trained models by modifying object attributes and scene properties in a controllable manner., Comment: Accepted in IJCV 2018
- Published
- 2017
- Full Text
- View/download PDF
149. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer
- Author
-
Yong-Han Su, Yi-Zhen Wu, David K. Ann, Jenny Ling-Yu Chen, and Ching-Ying Kuo
- Subjects
Cytology ,QH573-671 - Abstract
Abstract Obesity is a risk factor in various types of cancer, including breast cancer. The disturbance of adipose tissue in obesity highly correlates with cancer progression and resistance to standard treatments such as chemo- and radio-therapies. In this study, in a syngeneic mouse model of triple-negative breast cancer (TNBC), diet-induced obesity (DIO) not only promoted tumor growth, but also reduced tumor response to radiotherapy. Serpine1 (Pai-1) was elevated in the circulation of obese mice and was enriched within tumor microenvironment. In vitro co-culture of human white adipocytes-conditioned medium (hAd-CM) with TNBC cells potentiated the aggressive phenotypes and radioresistance of TNBC cells. Moreover, inhibition of both cancer cell autonomous and non-autonomous SERPINE1 by either genetic or pharmacological strategy markedly dampened the aggressive phenotypes and radioresistance of TNBC cells. Mechanistically, we uncovered a previously unrecognized role of SERPINE1 in DNA damage response. Ionizing radiation-induced DNA double-strand breaks (DSBs) increased the expression of SERPINE1 in cancer cells in an ATM/ATR-dependent manner, and promoted nuclear localization of SERPINE1 to facilitate DSB repair. By analyzing public clinical datasets, higher SERPINE1 expression in TNBC correlated with patients’ BMI as well as poor outcomes. Elevated SERPINE1 expression and nuclear localization were also observed in radioresistant breast cancer cells. Collectively, we reveal a link between obesity and radioresistance in TNBC and identify SERPINE1 to be a crucial factor mediating obesity-associated tumor radioresistance.
- Published
- 2023
- Full Text
- View/download PDF
150. SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth
- Author
-
Shu-Jyuan Yang, Jui-An Pai, Cheng-Jung Yao, Chung-Huan Huang, Jenny Ling‑Yu Chen, Chung-Hao Wang, Ke-Cheng Chen, and Ming-Jium Shieh
- Subjects
Chemo-radiotherapy ,7-Ethyl-10-hydroxycamptothecin ,Human serum albumin ,Hyaluronic acid ,Abscopal effect ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Chemo-radiotherapy is the combined chemotherapy and radiotherapy on tumor treatment to obtain the local radiosensitization and local cytotoxicity of the tumor and to control the microscopic metastatic disease. Methods In this study, 7-ethyl-10-hydroxycamptothecin (SN38) molecules could be successfully loaded into human serum albumin (HSA)–hyaluronic acid (HA) nanoparticles (SH/HA NPs) by the hydrophobic side groups of amino acid in HSA. Results HSA could be used to increase the biocompatibility and residence time of the nanoparticles in the blood, whereas HA could improve the benefits and overall treatment effect on CD44-expressing colorectal cancer (CRC), and reduce drug side effects. In addition to its role as a chemotherapeutic agent, SN38 could be used as a radiosensitizer, able to arrest the cell cycle, and allowing cells to stay in the G2/M stage, to improve the sensitivity of tumor cells to radiation. In vivo results demonstrated that SH/HA NPs could accumulate in the tumor and produce significant tumor suppression, with no adverse effects observed when combined with γ-ray irradiation. This SH/HA NPs-medicated chemo-radiotherapy could induce an anti-tumor immune response to inhibit the growth of distal tumors, and produce an abscopal effect. Conclusions Therefore, this SN38-loaded and HA-incorporated nanoparticle combined with radiotherapy may be a promising therapeutic artifice for CRC in the future.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.